Cargando…
MON-081 Mathematical Modeling of Residual Endogenous FT4 Synthesis and Exogenous L-Thyroxine Administration over the First 2 Years of Life in Infants with Congenital Hypothyroidism
L-Thyroxine (L-T4) is the treatment of choice of congenital hypothyroidism (CH). Longitudinal measurements of free T4 (FT4) serum concentrations were collected over the first two years of life with oral L-T4 treatment in infants with CH. Purpose of this study was to develop an integrated mathematica...
Autores principales: | Leroux, Stéphanie, Marc, Pfister, Welzel, Tatjana, Gächter, Pascal, Konrad, Daniel, L’Allemand, Dagmar, Szinnai, Gabor, Koch, Gilbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208082/ http://dx.doi.org/10.1210/jendso/bvaa046.1245 |
Ejemplares similares
-
MON-102 Serum Concentrations of FT4 and TSH in the First Six Months of L-Thyroxine Treatment in Infants with Congenital Hypothyroidism: Target Attainment Rates Should Be Improved
por: Leroux, Stéphanie, et al.
Publicado: (2020) -
Modeling of levothyroxine in newborns and infants with congenital hypothyroidism: challenges and opportunities of a rare disease multi-center study
por: Koch, Gilbert, et al.
Publicado: (2021) -
Clinically practical pharmacometrics computer model to evaluate and personalize pharmacotherapy in pediatric rare diseases: application to Graves' disease
por: Steffens, Britta, et al.
Publicado: (2023) -
FRI478 Pharmacometrics-based Computer Model Utilizing Heart Rate To Monitor Thyroid Function In Children With Graves' Disease
por: Steffens, Britta, et al.
Publicado: (2023) -
MON-LB081 Pituitary Adenomas: A Pan-genomic Classification
por: NEOU, Mario, et al.
Publicado: (2019)